* A corporate client of Hybridan LLP
** Arranged by type of listing and date of announcement
*** Alphabetically arranged
**** Potential means Intention to Float (ITF) has been announced
Dish of the day
Admissions:
None
Delistings:
DX Group Plc (DX..L) has left AIM
What’s baking in the oven? **
Potential**** Initial Public Offerings:
25 January: Media reports that London-based investment firm Fuel Ventures has launched a £50m Venture Capital Trust (VCT) to be listed on the LSE. The VCT has been launched with support from Titan Alternatives Ltd and will target thirty investments in high-growth tech innovation over the next three years. The VC firm said funds from the VCT will co-invest with the existing Fuel Ventures Enterprise Investment Scheme (EIS) portfolio.
12 January: The London Tunnels PLC announces its intention to seek Admission to the Standard Segment of the Official List and to trading on the Main Market of the LSE. The Company plans to restore, adaptively reuse and bring back to life the Kingsway Exchange Tunnels in Central London, originally built in the early 1940’s, and designed to shelter people during the London Blitz. The Company has successfully raised approximately £10m from investors and aims to admit its Ordinary Shares at a price of £2.00 per share to the Main Market. The Company is expected to have a market capitalisation of approximately £123m on Admission. Expected Admission before the end of January 2024.
2 October 2023: Tekcapital (TEK) announced intention to spin off and IPO MicroSalt: the developer of salt-producing technology designed to deliver full flavor with less sodium, announces the launch of an exempt public offer of shares to retail investors for up to £2.5m via PrimaryBid as part of its spin out from AIM listed Tekcapital plc (TEK.L) and £3.1m fundraise and expected size of primary offer. Microsalt announced revenues of US$0.638m in 2022, its first year of retail sales of SaltMe Crisp brand and Microsalt salt shakers in US based supermarkets and through Amazon US. AIM Admission delayed, expected 1 February 2024.
Reverse Takeovers:
30 January: Location Sciences Group Plc (LSAI) is proposing to acquire the entire issued share capital of Sorted Holdings Limited (Sorted) for a nominal consideration of £1.00 (Acquisition). Sorted operates a software-as-a-service (SaaS) business model providing delivery experience software which serves ecommerce retailers - from large, global enterprises to smaller, independent start-ups. Pursuant to Rule 14 of the AIM Rules for Companies, the Acquisition constitutes a reverse takeover. Capital to be raised on Admission is approximately £2.0m via a subscription for new Ordinary Shares. Anticipated market capitalisation on Admission is approximately £6.68m. Expected AIM Admission date is 19 February 2024.
Change of Market:
None
Banquet Buffet***
Argentex Group 56.9p £64.5m (AGFX.L)
The provider of currency management and payment solutions to international institutions and corporates, issues a trading update for the year ended 31 December 2023. The Board now confirms that it expects revenues for the twelve months to 31 December 2023 of approximately £49.8m, compared to £50.4m for the twelve months to 31 December 2022, and operating profit of not less than £8.0m, compared with £11.3m for the same period in 2022. Argentex further announces the appointment of Guy Rudolph as Interim Chief Financial Officer with effect from 31 January 2024. Guy is a qualified chartered accountant and began his career at PwC before joining Vodafone where he spent 16 years.
Cambridge Cognition Holdings 52p £18.2m (COG.L)
A Company which develops and markets digital solutions to assess brain health, announces a trading update for the year ended 31 December 2023. Revenue growth of 7% to £13.5m (2022: £12.6m), however adjusted operating loss was £1.2m for the year (2022: £0.1m profit), albeit better than market expectation. The Company holds cash balance of £3.2m at 31 December 2023 (31 December 2022: £8.3m). During 2023 the Company announced acquisitions of eClinicalHealth Limited (Clinpal) and Winterlight Labs Inc both of which have been fully integrated into the Group and annualised cost savings in excess of £1.5m have been realized. The contracted order book remains at the end of 2023 at £17.2m (£17.6m at 31 December 2022), with at least £8.0m expected to be recognised as revenue in 2024.
hVIVO 28.75p £195.6m (HVO.L)
A Company focusing in testing infectious and respiratory disease products using human challenge clinical trials, announces an unaudited trading update for the year ended 31 December 2023. Full year revenue of £56.0m, an increase of 15.5% (2022: £48.5m), EBITDA margins increased to c.22% (2022: 18.7%) and the Company held cash of £37.0m as at 31 December 2023 (31 December 2022: £28.4m) The Company have a weighted contracted orderbook of £80m as at 31 December 2023 (31 December 2022: £76m). As a result of the current strong outlook and performance of the business, the Company expects to achieve revenues of £62m in 2024.
Kromek Group 5.8p £34.8m (KMK.L)
A developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, announces its unaudited interim results for the six months ended 31 October 2023. Revenue increased to £7.1m (H1 2023: £6.8m) and gross margin improved to 54.2% (H1 2023: 40.4%). Adjusted EBITDA loss reduced to £0.1m (H1 2023: £2.7m loss). Loss before tax reduced to £3.5m (H1 2023: £5.7m loss) and the Company had cash and cash equivalents at 31 October 2023 of £3.7m (30 April 2023: £1.1m). The Company announced a new collaboration agreement entered, post period, with a global blue-chip technology solutions provider to develop CZT-based detectors for photon counting CT applications in medical imaging and the Company remain on track to deliver record revenues for full year 2024 and positive EBITDA.
Northcoders Group 152.5p £12.2m (CODE.L)
A UK technology training business, provides the following trading update for the year ended 31 December 2023 . Unaudited revenues for the period increased by 27% to £7.1m (FY-2022: £5.6m), driven by accelerating demand for digital training and the Group has £1.6m of cash as at 31 December 2023 and net cash of £0.8m. In FY-2023 Northcoders' core B2C Bootcamp Division experienced record growth, receiving 8,535 registrations (FY-2022: 4,615) across its software development, data engineering and cloud engineering (DevOps) programmes. The Group reports that underlying FY-2023 trading is in line with revised market expectations.
Petards Group* 4.5p £2.5m (PEG.L)
The developer of advanced security and surveillance systems, announces that its subsidiary, QRO Solutions (QRO), has been recently awarded an order worth £0.4m for Artificial Intelligence (AI) enabled ANPR cameras. The order is the first for the supply and installation of QRO's newly developed Harrier AI ANPR cameras. The project forms part of a three year programme being undertaken by the end-user, with QRO having already secured and supplied other roadside ANPR equipment for the first year in 2023. This new order is expected to be fully delivered during 2024. The cameras will be installed at several strategic highway locations in the UK allowing QRO the opportunity to showcase the Harrier AI nationally to existing and potential police force customers.
Pressure Technologies 32p £12.4m (PRES.L)
The engineering group, announces its audited results for the 52 weeks to 30 September 2023 (FY23). Group revenue increased 29% to £32.0m (2022: £24.9m) as a result gross profit was up 68% to £8.9m at 28% margin (2022: £5.3m at 21% margin). Adjusted EBITDA increased to £2.1m (2022: Adjusted EBITDA loss of £0.9m) and adjusted operating profit increased to £0.6m (2022: adjusted loss of £2.6m). The Company holds net debt of £2.4m (2022: £3.5m); Net bank borrowings, excluding asset finance lease liabilities and right of use asset lease liabilities, of £nil (2022: £0.6m). The Board expects the Group's full-year FY24 revenue and adjusted EBITDA to be in-line with current market expectations.
Synectics 157.5p £28.0m (SNX.L)
A Company focusing on security and surveillance systems, announces that it has been awarded further contracts as part of a framework agreement with National Grid. The additional contracts, valued at approximately £4.0m, and will see Synectics deliver security improvement works across 13 new sites. Synectics was awarded its first contract under the framework agreement with National Grid in October 2022, and will now be deploying its services across 20 sites throughout National Grid's substantial estate. The works covered by these contracts are planned for completion in FY 2024.
Zenova Group 2.75p £2.9m (ZED.L)
The fire suppression and interdiction solutions Company, affirms the continued success of its recently announced B2B strategy in the signing of another European distribution agreement in Romania, with a partner attracted by the Company's certification standards across its paints and extinguisher products. The non-exclusive agreement between the Company and its new partner, Distreo SRL, covers the full suite of Zenova fire and temperature management products. Distreo has already paid for a pre-order lot of 500 of the Company's FX500 extinguishers and already launched a Romanian market specific website selling the Zenova FX500 aerosol extinguishers to end clients.
1Spatial Holdings 53p £58.7m (SPA.L)
A Company focusing on Location Master Data Management (LMDM) software and solutions, has secured a three-year contract with a Distribution System Operator for electricity and gas networks in Belgium. The contract is for geospatial data processing services and will see 1Spatial's 1Integrate product used for its unique data quality control and data validation capabilities, alongside 1Spatial's geospatial data production services. The total contract value to 1Spatial is EUR9.0m of which 1Spatial will deliver EUR4.1m including EUR0.3m in term software licence revenue. 1Spatial will utilise partners to deliver the balance of the work, with a total value EUR4.9m, over the three-year duration of the contract.
Status of this Note and Disclaimer
This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document is sent to you as market commentary only. As market commentary this document does not constitute any of (i) investment research and financial analysis or other forms of general recommendation relating to transactions in financial instruments for the purposes of the UK retained version of section B of annex I to Directive 2014/65/EU ("MIFID II Directive"); or (ii) investment research as defined in the UK retained version of article 36(1) of Commission Delegated Regulation 2017/565/EU made pursuant to the MIFID II Directive; or (iii) non-independent research (as such term is defined in the Financial Conduct Authority's Conduct of Business Sourcebook).
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.